Suppr超能文献

心脏病患者中累及希氏-浦肯野系统的三种室性心动过速的识别与消融

Identification and ablation of three types of ventricular tachycardia involving the his-purkinje system in patients with heart disease.

作者信息

Lopera Gustavo, Stevenson William G, Soejima Kyoko, Maisel William H, Koplan Bruce, Sapp John L, Satti S Dinakar, Epstein Laurence M

机构信息

Cardiovascular Division, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

J Cardiovasc Electrophysiol. 2004 Jan;15(1):52-8. doi: 10.1046/j.1540-8167.2004.03189.x.

Abstract

INTRODUCTION

Ventricular tachycardia (VT) with involvement of the His-Purkinje system (HPS) can be difficult to recognize in patients with heart disease, but it may be particularly susceptible to ablation targeting the HPS. This study defines the incidence and types of HPS involvement in VT.

METHODS AND RESULTS

Involvement of the HPS was sought during electrophysiologic study with catheter mapping in 234 consecutive patients referred for catheter ablation of recurrent VT associated with heart disease. HPS VT was observed in 20 (8.5%) patients (mean ejection fraction 29%+/- 17%); in 9 (11%) of 81 patients with nonischemic heart disease and 11 (7.1%) of 153 patients with coronary artery disease (P = NS). Three types of HPS VT were observed: 16 patients (group 1) had typical bundle branch reentry, 2 patients (group 2) had bundle branch reentry and interfascicular reentry, and 2 patients (group 3) had VT consistent with a focal origin in the distal HPS. In all three groups, the VT QRS had morphologic similarity to the sinus rhythm QRS. Ablation of HPS VT was successful in all patients in whom it was attempted but produced high-degree AV block in 6 (30%). In 12 patients (60%), other VTs due to reentry through scar also were inducible.

CONCLUSION

Involvement of the HPS in VT associated with heart disease has three distinct clinical forms, all of which are susceptible to ablation. Ablation often is not sufficient as the sole therapy due to other induced VT's and conduction abnormalities, requiring pacemaker and/or defibrillator implantation.

摘要

引言

在患有心脏病的患者中,累及希氏 - 浦肯野系统(HPS)的室性心动过速(VT)可能难以识别,但它可能对针对HPS的消融治疗特别敏感。本研究确定了VT中HPS受累的发生率和类型。

方法与结果

在对234例因与心脏病相关的复发性VT而接受导管消融治疗的连续患者进行电生理研究并使用导管标测时,探寻HPS受累情况。在20例(8.5%)患者中观察到HPS VT(平均射血分数29%±17%);在81例非缺血性心脏病患者中有9例(11%),在153例冠状动脉疾病患者中有11例(7.1%)(P = 无显著差异)。观察到三种类型的HPS VT:16例患者(第1组)有典型的束支折返,2例患者(第2组)有束支折返和分支间折返,2例患者(第3组)的VT符合HPS远端的局灶性起源。在所有三组中,VT的QRS形态与窦性心律的QRS形态相似。对HPS VT进行消融治疗的所有尝试均成功,但6例(30%)患者出现了高度房室传导阻滞。在12例患者(60%)中,还可诱发因通过瘢痕折返引起的其他VT。

结论

HPS在与心脏病相关的VT中的受累有三种不同的临床形式,所有这些形式都对消融敏感。由于其他诱发的VT和传导异常,消融通常不足以作为唯一的治疗方法,需要植入起搏器和/或除颤器。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验